{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:38:08Z","timestamp":1791229088329,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.brainres.2020.146729","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T23:30:44Z","timestamp":1581723044000},"page":"146729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Neurokinin receptors in drug and alcohol addiction"],"prefix":"10.1016","volume":"1734","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-527X","authenticated-orcid":false,"given":"Jesse R.","family":"Schank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0005","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1096\/fasebj.4.6.1969374","article-title":"Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms","volume":"4","author":"Helke","year":"1990","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ajmg.b.32241","article-title":"Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome","volume":"165B","author":"Sharp","year":"2014","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"11","key":"10.1016\/j.brainres.2020.146729_b0015","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/npp.2009.65","article-title":"Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence","volume":"34","author":"Seneviratne","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1530-0277.2008.00663.x","article-title":"The tachykinin receptor 3 is associated with alcohol and cocaine dependence","volume":"32","author":"Foroud","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"5383","key":"10.1016\/j.brainres.2020.146729_b0025","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1126\/science.281.5383.1640","article-title":"Distinct mechanism for antidepressant activity by blockade of central substance P receptors","volume":"281","author":"Kramer","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.brainres.2020.146729_b0030","unstructured":"Kramer, P.D., et al., The truth about Prozac: an exchange. New York Rev Books, 2008. 55(2): p. 54-5."},{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/JCP.0b013e31823608ca","article-title":"Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder","volume":"31","author":"Ratti","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2020.146729_b0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/0269881113480990","article-title":"Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies","volume":"27","author":"Ratti","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"5869","key":"10.1016\/j.brainres.2020.146729_b0045","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1126\/science.1153813","article-title":"Neurokinin 1 receptor antagonism as a possible therapy for alcoholism","volume":"319","author":"George","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-014-3665-4","article-title":"The neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental study","volume":"232","author":"Kwako","year":"2015","journal-title":"Psychopharmacology"},{"issue":"10081","key":"10.1016\/j.brainres.2020.146729_b0055","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(17)30823-1","article-title":"Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Prague","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.brainres.2020.146729_b0060","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.lfs.2003.09.039","article-title":"Tachykinins and tachykinin receptors: a growing family","volume":"74","author":"Pennefather","year":"2004","journal-title":"Life Sci."},{"issue":"5919","key":"10.1016\/j.brainres.2020.146729_b0065","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/303714a0","article-title":"Autoradiographic distribution of substance P receptors in rat central nervous system","volume":"303","author":"Quirion","year":"1983","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2020.146729_b0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(84)90470-0","article-title":"Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand","volume":"307","author":"Mantyh","year":"1984","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.brainres.2020.146729_b0075","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1046\/j.1440-1681.2000.03366.x","article-title":"Localization of tachykinin receptors and Fos-like immunoreactivity induced by substance P in guinea-pig brain","volume":"27","author":"Yip","year":"2000","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.brainres.2020.146729_b0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brainres.2009.11.014","article-title":"Neuronal pathways linking substance P to drug addiction and stress","volume":"1314","author":"Commons","year":"2010","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.brainres.2020.146729_b0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0143-4179(91)90141-5","article-title":"Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists","volume":"19","author":"Elliott","year":"1991","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(92)90215-P","article-title":"Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens","volume":"216","author":"Boix","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0095","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0091-3057(90)90572-Y","article-title":"Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area","volume":"37","author":"Barnes","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(92)90251-X","article-title":"Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat","volume":"213","author":"Overton","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2020.146729_b0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(94)00681-V","article-title":"Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices","volume":"273","author":"Seabrook","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/syn.20627","article-title":"The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area","volume":"63","author":"Lessard","year":"2009","journal-title":"Synapse"},{"issue":"11","key":"10.1016\/j.brainres.2020.146729_b0115","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0196-9781(00)00291-6","article-title":"The psychopharmacology of tachykinin NK-3 receptors in laboratory animals","volume":"21","author":"Massi","year":"2000","journal-title":"Peptides"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2020.146729_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(90)90105-K","article-title":"Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide","volume":"534","author":"Stoessl","year":"1990","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(90)91218-6","article-title":"Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide","volume":"506","author":"Dam","year":"1990","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1096-9861(19960826)372:3<395::AID-CNE5>3.0.CO;2-Y","article-title":"In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system","volume":"372","author":"Shughrue","year":"1996","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1476-5381.1992.tb14199.x","article-title":"The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro","volume":"105","author":"Keegan","year":"1992","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2020.146729_b0140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0143-4179(98)90075-0","article-title":"Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig","volume":"32","author":"Marco","year":"1998","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.brainres.2020.146729_b0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.euroneuro.2006.07.004","article-title":"Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function","volume":"17","author":"Gobbi","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0150","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1073\/pnas.98.4.1912","article-title":"Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function","volume":"98","author":"Santarelli","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.brainres.2020.146729_b0155","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1523\/JNEUROSCI.22-17-07730.2002","article-title":"Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity","volume":"22","author":"Conley","year":"2002","journal-title":"J. Neurosci."},{"issue":"18","key":"10.1016\/j.brainres.2020.146729_b0160","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1523\/JNEUROSCI.23-18-07155.2003","article-title":"Substance P Acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity","volume":"23","author":"Valentino","year":"2003","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0165","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1124\/mol.107.040113","article-title":"Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex","volume":"72","author":"Guiard","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.brainres.2020.146729_b0170","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/sj.npp.1301594","article-title":"Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission","volume":"33","author":"Ebner","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(77)90144-5","article-title":"Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides","volume":"136","author":"Guyenet","year":"1977","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2020.146729_b0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(83)90445-4","article-title":"Substance P excitation of rat locus coeruleus neurones","volume":"94","author":"Cheeseman","year":"1983","journal-title":"Eur. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.brainres.2020.146729_b0185","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/00001756-200210070-00024","article-title":"Modulation of brain stem monoamines and gamma-aminobutyric acid by NK1 receptors in rats","volume":"13","author":"Ma","year":"2002","journal-title":"NeuroReport"},{"issue":"2","key":"10.1016\/j.brainres.2020.146729_b0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0306-4522(96)00150-9","article-title":"Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation","volume":"74","author":"Jung","year":"1996","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/syn.10021","article-title":"Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801","volume":"43","author":"Bert","year":"2002","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0200","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0893-133X(02)00305-6","article-title":"Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus","volume":"27","author":"Liu","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.brainres.2020.146729_b0205","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1073\/pnas.0400794101","article-title":"Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats","volume":"101","author":"Ebner","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2003.10.057","article-title":"Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist","volume":"484","author":"Hutson","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2020.146729_b0215","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/jnr.20997","article-title":"Blockade of tachykinin NK1 receptors attenuates stress-induced rise of extracellular noradrenaline and dopamine in the rat and gerbil medial prefrontal cortex","volume":"84","author":"Renoldi","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2020.146729_b0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0006-8993(02)02476-9","article-title":"The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study","volume":"935","author":"Lejeune","year":"2002","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0225","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0143-4179(90)90037-Y","article-title":"Evidence for dose-dependent positively and negatively reinforcing effects of the substance P C-terminal analog DIME-C7","volume":"17","author":"Hasenohrl","year":"1990","journal-title":"Neuropeptides"},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0167-0115(91)90081-Q","article-title":"Naloxone blocks conditioned place preference induced by substance P and [pGlu6]-SP(6\u201311)","volume":"35","author":"Hasenohrl","year":"1991","journal-title":"Regul. Pept."},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0235","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0091-3057(87)90514-4","article-title":"Reinforcing properties of substance P in the lateral hypothalamus revealed by conditioned place preference","volume":"28","author":"Holzhauer-Oitzl","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.brainres.2020.146729_b0240","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0028-3908(88)90085-8","article-title":"Reinforcing properties of substance P in the region of the nucleus basalis magnocellularis in rats","volume":"27","author":"Holzhauer-Oitzl","year":"1988","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0245","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1523\/JNEUROSCI.4315-08.2009","article-title":"Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons","volume":"29","author":"Yu","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0250","first-page":"11","article-title":"Neurokinin 1 and opioid receptors: relationships and interactions in nervous system","volume":"1","author":"Xiao","year":"2016","journal-title":"Trans. Perioper. Pain Med."},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0255","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0091-3057(98)00090-2","article-title":"Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide","volume":"61","author":"Ciccocioppo","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8","key":"10.1016\/j.brainres.2020.146729_b0260","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/mp.2017.102","article-title":"Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential","volume":"23","author":"Sandweiss","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.brainres.2020.146729_b0265","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0028-3908(02)00295-2","article-title":"Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors","volume":"43","author":"Ripley","year":"2002","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0270","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/npp.2012.261","article-title":"The NK1 receptor antagonist L822429 reduces heroin reinforcement","volume":"38","author":"Barbier","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0275","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pbb.2006.04.011","article-title":"Effects of central neurokinin-1 receptor antagonism on cocaine- and opiate-induced locomotor activity and self-administration behaviour in rats","volume":"84","author":"Placenza","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-011-2469-z","article-title":"Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism","volume":"220","author":"Robinson","year":"2012","journal-title":"Psychopharmacology"},{"issue":"6783","key":"10.1016\/j.brainres.2020.146729_b0285","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/35012069","article-title":"Rewarding effects of opiates are absent in mice lacking the receptor for substance P","volume":"405","author":"Murtra","year":"2000","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.brainres.2020.146729_b0290","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1523\/JNEUROSCI.23-23-08271.2003","article-title":"Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse","volume":"23","author":"Gadd","year":"2003","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.brainres.2020.146729_b0295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nn872","article-title":"Neurobiological evidence for hedonic allostasis associated with escalating cocaine use","volume":"5","author":"Ahmed","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0300","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s002130051121","article-title":"Long-lasting increase in the set point for cocaine self-administration after escalation in rats","volume":"146","author":"Ahmed","year":"1999","journal-title":"Psychopharmacology"},{"issue":"5387","key":"10.1016\/j.brainres.2020.146729_b0305","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.282.5387.298","article-title":"Transition from moderate to excessive drug intake: change in hedonic set point","volume":"282","author":"Ahmed","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0310","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0893-133X(99)00133-5","article-title":"Persistent increase in the motivation to take heroin in rats with a history of drug escalation","volume":"22","author":"Ahmed","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0315","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0306-4522(94)90288-7","article-title":"Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat","volume":"59","author":"Johansson","year":"1994","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0320","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0169-328X(97)00338-0","article-title":"Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat","volume":"54","author":"Mathieu-Kia","year":"1998","journal-title":"Brain Res. Mol. Brain. Res."},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0325","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0306-4522(00)00530-3","article-title":"Differential effects of cocaine and methamphetamine on neurotensin\/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum","volume":"102","author":"Adams","year":"2001","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2020.146729_b0330","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0169-328X(92)90058-J","article-title":"Cocaine self-administration differentially alters mRNA expression of striatal peptides","volume":"13","author":"Hurd","year":"1992","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2020.146729_b0335","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-328X(00)00205-9","article-title":"Cocaine self-administration in rats differentially alters mRNA levels of the monoamine transporters and striatal neuropeptides","volume":"83","author":"Arroyo","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0340","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejphar.2004.08.006","article-title":"The NK(1) receptor antagonist WIN51708 reduces sensitization after chronic cocaine","volume":"499","author":"Davidson","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2020.146729_b0345","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1749-6632.2001.tb03562.x","article-title":"Neurokinin-1 receptor antagonists block acute cocaine-induced horizontal locomotion","volume":"937","author":"Kraft","year":"2001","journal-title":"Ann. N Y Acad. Sci."},{"issue":"5","key":"10.1016\/j.brainres.2020.146729_b0350","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/npp.2013.309","article-title":"The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking","volume":"39","author":"Schank","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2020.146729_b0355","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-004-1912-9","article-title":"Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats","volume":"177","author":"Placenza","year":"2004","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0360","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neulet.2005.07.050","article-title":"Activation of central neurokinin-1 receptors induces reinstatement of cocaine-seeking behavior","volume":"390","author":"Placenza","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.brainres.2020.146729_b0365","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1460-9568.2007.05491.x","article-title":"Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects","volume":"25","author":"Jocham","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0370","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1460-9568.2006.05041.x","article-title":"Neurokinin receptor antagonism attenuates cocaine's behavioural activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core","volume":"24","author":"Jocham","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0375","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuropharm.2009.05.008","article-title":"Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity","volume":"57","author":"Nwaneshiudu","year":"2009","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0380","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1471-4159.2010.06973.x","article-title":"NK-3 receptor antagonism prevents behavioral sensitization to cocaine: a role of glycogen synthase kinase-3 in the nucleus accumbens","volume":"115","author":"Nwaneshiudu","year":"2010","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0385","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1369-1600.2011.00409.x","article-title":"Decreased methylation of the NK3 receptor coding gene (TACR3) after cocaine-induced place preference in marmoset monkeys","volume":"18","author":"Barros","year":"2013","journal-title":"Addict Biol."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0390","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejphar.2006.03.010","article-title":"The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys","volume":"536","author":"De Souza Silva","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.brainres.2020.146729_b0395","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.peptides.2006.03.005","article-title":"Interaction of the tachykinin NK3 receptor agonist senktide with behavioral effects of cocaine in marmosets (Callithrix penicillata)","volume":"27","author":"de Souza Silva","year":"2006","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0400","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00213-010-1775-1","article-title":"Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice","volume":"209","author":"Thorsell","year":"2010","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0405","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neulet.2010.03.051","article-title":"Artificial microRNA-based neurokinin-1 receptor gene silencing reduces alcohol consumption in mice","volume":"475","author":"Baek","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2020.146729_b0410","article-title":"Bidirectional relationship between alcohol intake and sensitivity to social defeat: association with Tacr1 and Avp expression","author":"Nelson","year":"2017","journal-title":"Addict Biol."},{"issue":"10","key":"10.1016\/j.brainres.2020.146729_b0415","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00213-018-4976-7","article-title":"Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist","volume":"235","author":"Huang","year":"2018","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.brainres.2020.146729_b0420","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.biopsych.2012.12.027","article-title":"Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats","volume":"73","author":"Schank","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.brainres.2020.146729_b0425","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13280","article-title":"Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in wistar rats","author":"Ayanwuyi","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.brainres.2020.146729_b0430","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1530-0277.2008.00753.x","article-title":"Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats","volume":"32","author":"Simms","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.brainres.2020.146729_b0435","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuropharm.2018.05.005","article-title":"The neurokinin-1 receptor mediates escalated alcohol intake induced by multiple drinking models","volume":"137","author":"Sequeira","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2020.146729_b0440","article-title":"Substance P in the anterior thalamic paraventricular nucleus: promotion of ethanol drinking in response to orexin from the hypothalamus","author":"Barson","year":"2015","journal-title":"Addict Biol."},{"key":"10.1016\/j.brainres.2020.146729_b0445","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2019.06.023","article-title":"Escalated alcohol self-administration and sensitivity to yohimbine-induced reinstatement in alcohol preferring rats: potential role of neurokinin-1 receptors in the amygdala","volume":"413","author":"Nelson","year":"2019","journal-title":"Neuroscience"},{"issue":"23","key":"10.1016\/j.brainres.2020.146729_b0450","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1007\/s00213-014-3605-3","article-title":"Wistar rats acquire and maintain self-administration of 20 % ethanol without water deprivation, saccharin\/sucrose fading, or extended access training","volume":"231","author":"Augier","year":"2014","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0455","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-011-2201-z","article-title":"Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429","volume":"218","author":"Schank","year":"2011","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.brainres.2020.146729_b0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012527","article-title":"The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol","volume":"5","author":"Steensland","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0465","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0091-3057(91)90257-3","article-title":"The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats","volume":"38","author":"Perfumi","year":"1991","journal-title":"Pharmaco.l Biochem. Behav."},{"issue":"1","key":"10.1016\/j.brainres.2020.146729_b0470","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0361-9230(94)90050-7","article-title":"Selective agonists at NK3 tachykinin receptors inhibit alcohol intake in Sardinian alcohol-preferring rats","volume":"33","author":"Ciccocioppo","year":"1994","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0475","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0196-9781(97)00022-3","article-title":"Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors","volume":"18","author":"Polidori","year":"1997","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0480","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0196-9781(94)00219-V","article-title":"Subcutaneous injections of the tachykinin senktide reduce alcohol intake in alcohol-preferring rats","volume":"16","author":"Ciccocioppo","year":"1995","journal-title":"Peptides"},{"issue":"9","key":"10.1016\/j.brainres.2020.146729_b0485","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0196-9781(97)00189-7","article-title":"Stimulation of tachykinin NK-3 receptors in the nucleus basalis magnocellularis reduces alcohol intake in rats","volume":"18","author":"Ciccocioppo","year":"1997","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.brainres.2020.146729_b0490","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0196-9781(98)00038-2","article-title":"Sensitivity of brain sites to the inhibitory effect on alcohol intake of the tachykinin aminosenktide","volume":"19","author":"Panocka","year":"1998","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.brainres.2020.146729_b0495","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0306-4522(94)00425-5","article-title":"Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region","volume":"64","author":"Boix","year":"1995","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.brainres.2020.146729_b0500","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1097\/01.ALC.0000102412.53561.C6","article-title":"Neurokinin type-3 receptor stimulation impairs ethanol-associated appetitive behavior in Wistar rats","volume":"27","author":"Slawecki","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"12","key":"10.1016\/j.brainres.2020.146729_b0505","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1523\/JNEUROSCI.2736-13.2014","article-title":"Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling","volume":"34","author":"Dao","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2020.146729_b0510","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2015.07.009","article-title":"Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking","volume":"99","author":"Schank","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2020.146729_b0515","article-title":"Sex differences in oral oxycodone self-administration and stress-primed reinstatement in rats","author":"Fulenwider","year":"2019","journal-title":"Addict Biol."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2020.146729_b0520","first-page":"E125","article-title":"TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence","volume":"37","author":"Blaine","year":"2013","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0525","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2005.07.013","article-title":"Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder","volume":"59","author":"Keller","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2020.146729_b0530","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00259-011-1954-2","article-title":"A pharmacokinetic PET study of NK(1) receptor occupancy","volume":"39","author":"Zamuner","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.brainres.2020.146729_b0535","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/10799893.2013.843194","article-title":"Why receptor reserve matters for neurokinin1 (NK1) receptor antagonists","volume":"33","author":"Trist","year":"2013","journal-title":"J. Recept Signal Transduct. Res."},{"issue":"2","key":"10.1016\/j.brainres.2020.146729_b0540","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1369-1600.2011.00419.x","article-title":"Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers","volume":"18","author":"Walsh","year":"2013","journal-title":"Addict Biol."},{"issue":"5","key":"10.1016\/j.brainres.2020.146729_b0545","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/bcp.12004","article-title":"Pharmacokinetics and central nervous system effects of the novel dual NK1 \/NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers","volume":"75","author":"te Beek","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2020.146729_b0550","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0269881113517953","article-title":"Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET","volume":"28","author":"Ridler","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.brainres.2020.146729_b0555","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1476-5381.2010.00824.x","article-title":"Spinal or systemic TY005, a peptidic opioid agonist\/neurokinin 1 antagonist, attenuates pain with reduced tolerance","volume":"161","author":"Largent-Milnes","year":"2010","journal-title":"Br. J. Pharmacol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899320300858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899320300858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:06:21Z","timestamp":1757786781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899320300858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":111,"alternative-id":["S0006899320300858"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2020.146729","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurokinin receptors in drug and alcohol addiction","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2020.146729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146729"}}